11m
Bioliberty Raises $10.2 million to Build Functional Intelligence Capabilities for Post‑Acute Care
Since its seed round in 2023, the company has raised $17.5 million from a mix of public and private investors to fuel product development and commercialization. Bioliberty holds eight patents across ...
Hyperallergic’s editors sit down for an earnest conversation about the institution’s expanded building and inaugural ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results